Physicians trained in the identification and treatment of patients with unhealthy substance use continue to be in short supply, a problem that is exacerbated by an overdose epidemic driven by prescription drug abuse. Research and clinical skills are needed among three groups of physicians who are facing the current substance use epidemic: primary care physicians with patients experiencing unhealthy substance use; physicians caring for patients with HIV and Hepatitis C virus (HCV) infection; and those who treat patients with pain. This renewal grant application proposes funding for years 16-20 of the Clinical Addiction Research and Education (CARE) Program to expand upon previous successes to develop substance use disorder expertise among physician researchers and educators. The CARE Program has the following Specific Aims: (1a) To carry out a program in Addiction Medicine in order to train Chief Resident (CR) physician educators and their faculty mentors to teach state-of-the-art clinical care of patients with substance use and prescription drug abuse via continuation of the Chief Resident Immersion Training (CRIT) program. Enhanced topics in this application are safe and effective use of opioids for managing pain, addressing prescription drug abuse, and understanding the medical consequences of drug and alcohol use. (1b) To carry out a program in Addiction Medicine in order to prepare fellows from Infectious Disease (ID) and Pain Medicine specialties to incorporate substance use topics into their research by continuing to host the Fellow Immersion Training (FIT) program in conjunction with CRIT. Each fellow will develop an analytic plan and research proposal to investigate an addiction-related aspect of HIV, HCV, or prescription drug abuse/chronic pain. (2) To support medical trainees and early career physician faculty in the development of clinical addiction research careers by recruiting medical students, residents, fellows and junior faculty to be mentored by CARE Program faculty on addiction research studies. (3) To enable physicians and addiction researchers to be up-to-date on clinically relevant unhealthy substance use and addiction-related research ethics by producing and upgrading the research summary newsletter and website Alcohol, Other Drugs, and Health: Current Evidence (aodhealth.org), adding a focus on prescription drug abuse and fostering an online community. The CARE Program utilizes some of the most experienced of NIDA?s generalist physician investigators in a comprehensive effort to train a spectrum of physicians in clinical research methods and the medical care of patients with or at risk for drug use disorders. It will make important contributions to the development of the next generation of physician substance use researchers and to the dissemination of addiction research in order to provide better care for patients.

Public Health Relevance

The CARE Program is significant because it engages physicians in clinical research methods and equips them to identify and care for patients with or at risk for substance use disorders. The Program will continue to develop the skills of the next generation of physician substance use researchers and contribute to the dissemination of state-of-the-art clinical addiction practices.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Education Projects (R25)
Project #
3R25DA013582-19S1
Application #
9750950
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Wiley, Tisha R A
Project Start
2001-05-01
Project End
2022-04-30
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
19
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Weinstein, Zoe M; Gryczynski, Gabriela; Cheng, Debbie M et al. (2018) Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. Drug Alcohol Depend 189:166-171
Alford, Daniel P; Carney, Brittany L; Jackson, Angela H et al. (2018) Promoting addiction medicine teaching through functional mentoring by co-training generalist chief residents with faculty mentors. Subst Abus :1-7
Barocas, Joshua A; White, Laura F; Wang, Jianing et al. (2018) Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis. Am J Public Health 108:1675-1681
Hadland, Scott E; Bagley, Sarah M; Rodean, Jonathan et al. (2018) Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder. JAMA Pediatr 172:1029-1037
Morgan, Jake R; Schackman, Bruce R; Leff, Jared A et al. (2018) Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. J Subst Abuse Treat 85:90-96
Bagley, Sarah M; Cheng, Debbie M; Winter, Michael et al. (2018) Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests. Drug Alcohol Depend 192:245-249
Idrisov, Bulat; Lunze, Karsten; Cheng, Debbie M et al. (2017) Role of substance use in HIV care cascade outcomes among people who inject drugs in Russia. Addict Sci Clin Pract 12:30
Weinstein, Zoe M; Cheng, Debbie M; Quinn, Emily et al. (2017) Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine. Drug Alcohol Depend 170:9-16
Hui, David; Weinstein, Zoe M; Cheng, Debbie M et al. (2017) Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine. J Subst Abuse Treat 79:12-19
Trowbridge, Paul; Weinstein, Zoe M; Kerensky, Todd et al. (2017) Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat 79:1-5

Showing the most recent 10 out of 57 publications